COMP <GO>
MAZE vs IMCR // EV/EBITDA & P/E VALUATION
Maze Therapeutics Inc. (NASDAQ) VS. Immunocore Holdings plc (NASDAQ) • 15-METRIC TALLY: MAZE 2
— IMCR 2
■ METRIC PARITY
LAST: $31.93 (+0.63%) • MKT CAP: $1.77B
valuation
—
LAST: $31.27 (-4.11%) • MKT CAP: $1.61B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAZE VS. IMCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MAZE | IMCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 96.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.36% | -0.93% | -5.43 | IMCR | /fcf-yield <GO> |
| Operating Margin | — | -11.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -8.90% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 29.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.40 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | IMCR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.3 | 46.4 | +16.87 | MAZE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.77B | $1.61B | $163.3M | MAZE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MAZE REV | IMCR REV | MAZE GROSS % | IMCR GROSS % | MAZE FCF | IMCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $400.0M | — | 98.0% | -$112.7M | -$15.1M |
| FY 2024 | $167.5M | $310.2M | — | 98.0% | $74.8M | $20.9M |
| FY 2023 | — | $249.4M | — | — | — | $2.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MAZE // BETA —
IMCR // BETA —